Laboratory D-dimer measurement: Improved agreement between methods through calibration

Summary

Accurate and precise measurement of plasma D-dimer levels is important in the diagnosis and management of venous thromboembolism. Considerable variability in D-dimer results obtained using different methods has, however, been reported in multicentre studies. This study explored in two separate multicentre exercises the degree of precision amongst laboratory D-dimer measurements, and the degree by which inter-method agreement could be improved using a calibration curve model. The first exercise demonstrated generally good within-centre precision, with 82% of the centres reporting results for two identical but differently coded samples within 10% of each other. However, six centres reported results which would have excluded deep vein thrombosis (DVT) for one sample but failed to exclude DVT for the other, identical sample. In the second exercise, overall between-method precision of D-dimer results for two samples was shown to improve markedly when a calibration model was applied, using the consensus median values obtained by all participants for three “calibration plasmas” to recalculate D-dimer values. For centres reporting results in fibrinogen equivalent units (FEUs),between-centre coefficients of variation (CVs) fell from 25.9% to 11.6% and 22.4% to 7.7%, respectively, for the two samples. For centres reporting in ng/ml, CVs fell from 45.3–21.6% and 40.8–11.6%,respectively. In conclusion, improved harmonisation of D-dimer results by different methods may be achieved by a calibration model and common calibrant plasmas.

Keywords

D-dimer - DVT - harmonisation

• References

• 1 Horan JT, Francis CW. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation. Semin Thromb Hemost 2001; 27: 657-666.
• 2 Wells PS, Anderson DR, Ginsberg J. Assessment of deep vein thrombosis or pulmonary embolism by the combined use of clinical model and noninvasive diagnostic tests. Semin Thromb Hemost 2000; 26: 643-656.
• 3 Keeling DM, Mackie IJ, Moody A. et al. The diagnosis of deep vein thrombosis in symptomatic outpatients and the potential for clinical assessment and D-Dimer assays to reduce the need for diagnostic imaging. Br J Haematol 2004; 124: 15-25.
• 4 Goekoop RJ, Steeghs N, Niessen RWLM. et al. Simple and safe exclusion of pulmonary embolism in outpatients using quantitative D-Dimer and Wells’ simplified decision rule. Thromb Haemost 2007; 97: 146-150.
• 5 Palareti G, Legnani C, Cosmi B. et al. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thromb Haemost 2002; 87: 7-12.
• 6 de Maat MP, Meijer P, Nieuwenhuizen W. et al. Performance of semiquantitative and quantitative D-Dimer assays in the ECAT external quality assessment program. Semin Thromb Hemost 2000; 26: 625-630.
• 7 Tripodi A, Chantarangkul V. Performance of quantitative D-dimer methods: results of the Italian external quality assessment scheme. J Thromb Haemost 2007; 5: 184-185.
• 8 Jennings I, Kitchen S, Kitchen DP. et al. Laboratory D-Dimer Measurement in the exclusion of DVT: any nearer agreement?. Brit J Haematol 2006; 133 (01) 47.
• 9 Meijer P, Haverkate F, Kluft C. et al. A model for the harmonisation of test results of different quantitative D-Dimer methods. Thromb Haemost 2006; 95: 567-572.
• 10 Kitchen S, Walker ID, Woods TAL. et al. on behalf of the Steering Committee of the UK NEQAS in Blood Coagulation.. Thromboplastin related Differences in the Determination of International Normalised Ratio: A Cause for Concern?. Thromb Haemost 1994; 72: 426-429.
• 11 Medicines and Healthcare Products Regulatory Agency Evaluation Report MHRA 03088.. Medicines and Healthcare Products Regulatory Agency of UK Department of Health 2003. Hannibal House, Elephant and Castle, London,; SE1 6TQ.
• 12 Gardiner C, Pennaneac’h C, Walford C. et al. An evaluation of rapid D-dimer assays for the exclusion of deep vein thrombosis. Br J Haematol 2005; 128: 842-848.
• 13 Dempfle CE, Zips S, Ergul H. et al. The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT study group. Thromb Haemost 2001; 85: 671-678.
• 14 Dempfle CE. D-Dimer: Standardisation versus harmonisation. Thromb Haemost 2006; 95: 399-400.